These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1067 related articles for article (PubMed ID: 34474680)

  • 1. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic ability of
    Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M
    Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value on SUV-derived parameters assessed on
    Liao X; Liu M; Li S; Huang W; Guo C; Liu J; Xiong Y; Zhang J; Fan Y; Wang R
    BMC Med Imaging; 2023 Apr; 23(1):49. PubMed ID: 37020286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study.
    Zhai X; Guo Y; Qian X
    Med Sci Monit; 2020 Jun; 26():e922675. PubMed ID: 32483109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is FDG-PET/CT used correctly in the combined approach for nodal staging in NSCLC patients?
    Simsek FS; Comak A; Asik M; Kuslu D; Balci TA; Ulutas H; Koroglu R; Kekilli E; Akatli A; Elmali F; Yalcin NC; Akyol H
    Niger J Clin Pract; 2020 Jun; 23(6):842-847. PubMed ID: 32525121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of Volumetric Metabolic Parameters on Preoperative FDG PET/CT for Predicting Tumor Lymphovascular Invasion in Non-Small Cell Lung Cancer.
    Li C; Tian Y; Shen Y; Wen B; He Y
    AJR Am J Roentgenol; 2021 Dec; 217(6):1433-1443. PubMed ID: 33978465
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.
    Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N
    Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic value of metabolic, morphological and heterogeneous parameters of 18F-FDG PET/CT in mediastinal lymph node metastasis of non-small cell lung cancer.
    Hua J; Li L; Liu L; Liu Q; Liu Y; Chen X
    Nucl Med Commun; 2021 Nov; 42(11):1247-1253. PubMed ID: 34269750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
    Bae SU; Won KS; Song BI; Jeong WK; Baek SK; Kim HW
    Cancer Imaging; 2018 Sep; 18(1):32. PubMed ID: 30217167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer.
    Mattes MD; Moshchinsky AB; Ahsanuddin S; Rizk NP; Foster A; Wu AJ; Ashamalla H; Weber WA; Rimner A
    Clin Lung Cancer; 2015 Nov; 16(6):e253-8. PubMed ID: 26163919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer.
    Park SY; Yoon JK; Park KJ; Lee SJ
    Cancer Imaging; 2015 Dec; 15():21. PubMed ID: 26694918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Investigation of the Relationship Between
    Kandemir O; Demir F
    Curr Radiopharm; 2024; 17(1):111-116. PubMed ID: 37644744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on
    Jin F; Qu B; Fu Z; Zhang Y; Han A; Kong L; Yu J
    Clin Lung Cancer; 2018 Jan; 19(1):e101-e108. PubMed ID: 28690012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinative evaluation of primary tumor and lymph nodes in predicting pelvic lymphatic metastasis in early-stage cervical cancer: A multiparametric PET-CT study.
    Li K; Sun H; Guo Q
    Eur J Radiol; 2019 Apr; 113():153-157. PubMed ID: 30927941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [
    Li Y; Zhang Y; Guo Z; Hou P; Lv J; Ke M; Liu S; Li S; Yin W; He J; Wang X
    Cancer Imaging; 2024 Jun; 24(1):68. PubMed ID: 38831354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized visual reading of F18-FDG-PET in patients with non-small cell lung cancer scheduled for preoperative thoracic lymph node staging.
    Rogasch JM; Apostolova I; Steffen IG; Steinkrüger FL; Genseke P; Riedel S; Wertzel H; Achenbach HJ; Kalinski T; Schultz M; Schreiber J; Amthauer H; Furth C
    Eur J Radiol; 2016 Aug; 85(8):1345-50. PubMed ID: 27423672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A decision tree model for predicting mediastinal lymph node metastasis in non-small cell lung cancer with F-18 FDG PET/CT.
    Pak K; Kim K; Kim MH; Eom JS; Lee MK; Cho JS; Kim YS; Kim BS; Kim SJ; Kim IJ
    PLoS One; 2018; 13(2):e0193403. PubMed ID: 29486012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
    Liao S; Penney BC; Wroblewski K; Zhang H; Simon CA; Kampalath R; Shih MC; Shimada N; Chen S; Salgia R; Appelbaum DE; Suzuki K; Chen CT; Pu Y
    Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic tumor volume derived from
    Ding C; Mao X; Li N; Huang M; Huang Z; Bao W; Li H; Fan J
    Hell J Nucl Med; 2022; 25(1):63-70. PubMed ID: 35503557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.